Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/2/17 → 5/2/20 |
Funding
- Quintiles, Inc. (Prot# MLN0002-3026 // Prot# MLN0002-3026)
- Takeda Development Center Americas, Inc. (Prot# MLN0002-3026 // Prot# MLN0002-3026)
Prot# MLN0002-3026: A Randomized, Double-Blind, Double-Dummy, Multicenter, Active-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab IV Compared to Adalimumab SC in Subjects with Ulcerative Colitis
Project: Research project